Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy

A M Thackray1, H J Field

  • 1Centre for Veterinary Science, Cambridge University Veterinary School, Cambridge CB3 0ES, United Kingdom.

Insights

Famciclovir and valaciclovir treatments reduced mortality in herpes simplex virus type 2 (HSV-2) infected mice. Valaciclovir therapy, however, allowed persistent infectious virus detection in neural tissues post-treatment.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Herpes simplex virus type 2 (HSV-2) causes significant morbidity and mortality.
  • Antiviral therapies are crucial for managing HSV-2 infections.

Purpose of the Study:

  • To evaluate the efficacy of famciclovir and valaciclovir in treating HSV-2 infection in a murine model.
  • To investigate the impact of these antivirals on viral clearance from infected tissues.

Main Methods:

  • Young adult mice were inoculated with HSV-2 in the ear pinna.
  • Mice received oral famciclovir or valaciclovir therapy for varying durations.
  • Infectious virus presence was monitored daily in ear pinna, brain stem, and trigeminal ganglia.

Main Results:

  • Both famciclovir and valaciclovir significantly reduced clinical signs and mortality.
  • Famciclovir treatment resulted in no detectable infectious virus after 9 days.
  • Valaciclovir treatment allowed persistent detection of infectious virus in neural tissues for up to 7 days after discontinuation.

Conclusions:

  • Famciclovir demonstrated complete viral clearance in this model.
  • Valaciclovir's efficacy in neural tissue clearance requires further investigation.
  • Potential mechanisms for persistent virus in neural tissue despite valaciclovir therapy are discussed.